Patents by Inventor Wanzhu Jin

Wanzhu Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF POLYCYSTIC OVARY SYNDROME
    Publication number: 20170360843
    Abstract: Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine syndrome associated with a high risk for the development of insulin resistance, type 2 diabetes (T2D), obesity, dyslipidemia, and cardiovascular disease. There are no known therapies for the 9-18% of women afflicted with PCOS. Provided herein are methods for the treatment and/or prevention of at least one symptom of PCOS. Also provided herein are methods for the treatment and/or prevention of PCOS.
    Type: Application
    Filed: June 17, 2016
    Publication date: December 21, 2017
    Inventors: Xiaoxue YUAN, Tao HU, Yuanyuan HUANG, Wanzhu JIN, Zi-Jiang CHEN
  • Inhibiting striated muscle activator of RHO (stars) to improve glycemic control
    Patent number: 8815799
    Abstract: Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of Striated Muscle Activator of Rho Signaling (STARS) activity, and methods of identifying new compounds for use in the described methods of treatment.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: August 26, 2014
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Mary Elizabeth Patti, Wanzhu Jin, Allison B. Goldfine
  • Inhibiting serum response factor (SRF) to improve glycemic control
    Patent number: 8524661
    Abstract: Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment.
    Type: Grant
    Filed: July 11, 2011
    Date of Patent: September 3, 2013
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Mary Elizabeth Patti, Wanzhu Jin, Allison B. Goldine
  • INHIBITING STRIATED MUSCLE ACTIVATOR OF RHO (STARS) TO IMPROVE GLYCEMIC CONTROL
    Publication number: 20130197058
    Abstract: Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of Striated Muscle Activator of Rho Signaling (STARS) activity, and methods of identifying new compounds for use in the described methods of treatment.
    Type: Application
    Filed: June 3, 2011
    Publication date: August 1, 2013
    Applicant: JOSLIN DIABETES CENTER, INC.
    Inventors: Mary Elizabeth Patti, Wanzhu Jin, Allison B. Goldfine
  • Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control
    Publication number: 20120028895
    Abstract: Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment.
    Type: Application
    Filed: July 11, 2011
    Publication date: February 2, 2012
    Applicant: Joslin Diabetes Center, Inc.
    Inventors: Mary Elizabeth Patti, Wanzhu Jin, Allison B. Goldfine
  • Inhibiting serum response factor (SRF) to improve insulin sensitivity
    Patent number: 8003606
    Abstract: Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: August 23, 2011
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: Mary Elizabeth Patti, Wanzhu Jin, Allison B. Goldfine
  • Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control
    Publication number: 20100010074
    Abstract: Described are methods of improving glycemic control/improving insulin sensitivity by administering an inhibitor of serum response factor (SRF) activity, and methods of identifying new compounds for use in the described methods of treatment.
    Type: Application
    Filed: June 5, 2009
    Publication date: January 14, 2010
    Applicant: Joslin Diabetes Center, Inc.
    Inventors: Mary Elizabeth Patti, Wanzhu Jin, Allison B. Goldfine